Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, December 22, 2017
PixarBio developers of NeuroRelease NR14 announce an agreement between PSI, a Lubrizol Corporation Company, to cGMP manufacture PixarBio’s NR14.
read more
Tuesday, January 29, 2019
Pivot announced the company has entered into a contract manufacturing agreement with Growpacker to produce Pivot's topical gels, creams and beverages for the California cannabis market.
read more
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, is launching two complementary initiatives to transform pharmacovigilance (PV) in response to growing member demand.
read more
Piramal Pharma Solutions (PPS) announced that its Grangemouth, UK facility has completed production of its 1,500th antibody-drug conjugate (ADC) batch. The milestone batch represents a commercial oncology product.
read more
Thursday, September 19, 2024
Piramal Pharma Limited embarked on its sustainability journey as the Science Based Targets initiative (SBTi) officially validated the company’s near-term greenhouse gas (GHG) emission reduction targets.
read more
Piramal Pharma announced the company will be partnering with Epirium Bio on a manufacturing relationship for new orphan drugs.
read more
Tuesday, December 21, 2021
Piramal Pharma Limited (PPL) announced an investment of INR101.77cr in Yapan Bio Pvt Ltd (“Yapan”) of Hyderabad, India, augmenting the capabilities of its Contract Development and Manufacturing Organization (CDMO) business, Piramal Pharma Solutions (...
read more
Wednesday, March 29, 2023
Piramal Pharma Solutions announced that the company has completed the successful integrated development and manufacturing of drug substance and drug product for Brenzavvy™ (bexagliflozin), TheracosBio’s recently approved treatment for type 2 diabetes...
read more
PPL's, Piramal Pharma Solutions, announced the Company has entered into a Master Services Agreement.
read more
Wednesday, November 19, 2025
Piramal Pharma Solutions announced that its Grangemouth, UK facility has received updated MHRA GMP certificates following a successful compliance report and desktop inspection.
read more
Piramal Pharma Limited's Pharma Solutions business announced a new production block has come online at the company's drug product site in Pithampur, in the state of Madhya Pradesh, India.
read more
Tuesday, December 19, 2023
Piramal Pharma Solutions (PPS), a key player in Contract Development and Manufacturing Organization (CDMO) services under Piramal Pharma Ltd., has inaugurated its advanced antibody-drug conjugate (ADC) manufacturing facility in Grangemouth, Scotland,...
read more
Thursday, August 18, 2016
Ash Stevens, Inc., a provider of global contract pharmaceutical drug substance development and active pharmaceutical ingredient (API) manufacturing services, is pleased to announce that the company has been acquired by Piramal Pharma Solutions, a ...
read more
Piramal Pharma Solutions has entered a manufacturing and supply arrangement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, a commercial dermatology company.
read more
This launch is a key element of the company's broader $90 million investment plan to extend U.S.-based manufacturing capabilities, announced last year
read more